ymdd motif mutation profile among patients receiving liver transplant due to hepatitis b virus infection with long term lamivudine/immunoglobulin therapy
نویسندگان
چکیده
conclusions although the patients carrying m204i mutation were more likely to show lack of responses to lam therapy, lam replacing by other nucleoside/tide analogs plus hbig maybe still effective in decreasing hepatitis b recurrence after liver transplantation. however, it is suggested that drug resistance test should be considered by clinicians during therapeutic management to avoid the following viral breakthrough. results totally, according to the laboratory criteria there were 13 cases with detectable hbv genome, while the mean liver enzyme levels were higher in recurrent patients and hbsag was detected only in four out of the 13 cases. phylogenetic analysis demonstrated that all isolated genomes belonged to genotype d. critical m204i mutation, as a proof for resistance to lam, was detected among 46% of the subjects and natural entecavir resistance (s202i) was also distinguished in one subject. viral quantification showed higher titer in lam resistant group in comparison to the group with undetectable drug resistance mutant (p > 0.05). patients and methods thirty patients with liver transplantation due to hbv were enrolled, while dna level remained under detection limit of 50 iu/ml before transplantation and abnormal higher levels of liver enzymes after lt. the hbv genome detection was performed by two different polymerase chain reaction methods following viral quantification by commercial real-time pcr. hbsag detection, besides liver function tests were conducted as complementary assays. to assess nucleotide analogue mutations, the major part of polymerase gene (aa 80 - 240) was amplified by nested-pcr, introduced to sequencing and subjected to phylogenetic analysis. objectives the current study aimed to evaluate the ymdd motif mutations profile among the patients undergoing lt infected with hbv and treated with lam/hbig at least for one year. background recurrence of hepatitis b virus infection in patients undergoing liver transplanted (lt) is a serious and often fatal problem. lamivudine (lam) and hepatitis b immunoglobulin (hbig) are widely used to manage hepatitis b recurrence after liver transplantation. however, the outcomes in patients are less elucidated.
منابع مشابه
YMDD Motif Mutation Profile Among Patients Receiving Liver Transplant Due to Hepatitis B Virus Infection With Long Term Lamivudine/Immunoglobulin Therapy
BACKGROUND Recurrence of Hepatitis B Virus infection in patients undergoing liver transplanted (LT) is a serious and often fatal problem. Lamivudine (LAM) and Hepatitis B Immunoglobulin (HBIG) are widely used to manage hepatitis B recurrence after liver transplantation. However, the outcomes in patients are less elucidated. OBJECTIVES The current study aimed to evaluate the YMDD motif mutatio...
متن کاملThe Absence of Hepatitis C Virus Infection Among Patients with Hepatitis B virus in Mashhad, Iran
Background and Aims: Many studies have provided evidence for the role of hepatitis B and C viruses in the development of liver cancer. Although the routine treatment is available for both conditions, no definite guideline is available to treat patients dually infected with HBV and HCV. This study was performed to determine the frequency of HBV/HCV-coinfection in Mashhad, North-East of Iran. Mat...
متن کاملRate of YMDD motif mutants in lamivudine-untreated Iranian patients with chronic hepatitis B virus infection.
BACKGROUND Lamivudine is used for the treatment of chronic hepatitis B patients. Recent studies show that the YMDD motif mutants (resistant hepatitis B virus) occur as natural genome variability in lamivudine-untreated chronic hepatitis B patients. In this study we aimed to determine the rate of YMDD motif mutants in lamivudine-untreated chronic hepatitis B patients in Iran. PATIENTS AND METH...
متن کاملEvaluation of miR-101 Level in Patients with Chronic Hepatitis B Virus Infection and Liver Cirrhosis
ABSTRACT Background and Objective: MiRNAs are small RNAs that are expressed in most eukaryotes, and can regulate gene expression by attaching to the 3’ end of target mRNA. MicroRNA-101 (miR-101) post-transcriptional regulation is important for host-virus interactions. In addition, miR-101 has a tumor suppressive role in liver cancer and metastasis, an...
متن کاملprevention of hepatitis b recurrence in liver transplant patients using oral antiviral therapy without long-term hepatitis b immunoglobulin
متن کامل
Long-Term Outcomes of Simultaneous Liver-Kidney Transplant Patients with Hepatitis B Compared to with Liver Transplant Alone
BACKGROUND The number and survival rate of simultaneous liver-kidney transplant (SLKT) recipients have increased dramatically since 2002. However, the long-term effectiveness of SLKT in patients with hepatitis B is unknown. MATERIAL/METHODS Forty-six patients who visited the Organ Transplant Center of the Shanghai First People's Hospital between January 2001 and May 2005 had hepatitis B virus...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
hepatitis monthlyجلد ۱۵، شماره ۷، صفحات ۰-۰
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023